Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation
BACKGROUND: Platelets (PLTs) contain purinergic receptors for ATP (P2X(1)) and ADP (P2Y(1) and P2Y(12)) that rapidly desensitize upon stimulation with these nucleotides. In vivo, this is antagonized by ectonucleotidases on the surface of endothelial cells and white blood cells (WBCs). The receptor desensitization of ATP- and ADP-induced responses of PLTs stored in plasma without WBCs was investigated. STUDY DESIGN AND METHODS: ATP- and ADP-induced PLT shape change (shear-induced) aggregation and Ca2+ signaling were measured in the presence or absence of plasma. Degradation of nucleotides in plasma was quantified by high-performance liquid chromatography. RESULTS: Washed PLTs became refractory for ATP and ADP in shape change, aggregation, and Ca2+ responses during a 90-minute incubation at 37 degrees C. The PLT responses mediated by P2X(1), P2Y(1), and P2Y(12) receptors gradually reduced or disappeared. When plasma was present, however, the PLTs persistently showed high responses to ATP and ADP. Heat treatment of plasma abolished this effect. Also under conditions of flow and high shear, PLTs in plasma kept high P2X(1) activity, mediating aggregate formation. In isolated plasma, not containing WBCs, nucleotides were degraded in the order of ADP/UDP > ATP/UTP. Degradation of ATP was partly inhibited by blocking the ecto-NTPDase CD39, whereas degradation of both ATP and ADP was inhibited by blocking ectopyrophosphatase/phosphodiesterase activity. Part of the nucleotide-degrading activities appeared to be membrane-bound. CONCLUSION: Ectonucleotidases in plasma preserve the functionality of P2X(1) and P2Y receptors. Upon PLT storage, these plasma activities are essential to ensure adequate (shear-dependent) formation of aggregates and thrombi.
机构:
Millennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USAMillennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USA
Conley, PB
;
Delaney, SM
论文数: 0引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USAMillennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USA
机构:
Millennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USAMillennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USA
Conley, PB
;
Delaney, SM
论文数: 0引用数: 0
h-index: 0
机构:
Millennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USAMillennium Pharmaceut Inc, Dept Cardiovasc Biol, San Francisco, CA 94080 USA